Treating hypertension and prehypertension in older people: When, whom and how

Maturitas

Volumn 80, Issue 1, 2015, Pages 31-36

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Antihypertensive drugs; Cardiovascular events; Hypertension; Lifestyle measures; Prehypertension; Stroke

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID; NEBIVOLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PSYCHOTROPIC AGENT; THIAZIDE DIURETIC AGENT; TRANDOLAPRIL PLUS VERAPAMIL;

AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CALCIUM INTAKE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL INTAKE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONSENSUS; DIABETES MELLITUS; DIET RESTRICTION; DRUG EFFECT; FAINTNESS; FALLING; FAT INTAKE; FRACTURE; HEALTH CARE COST; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; LIFESTYLE MODIFICATION; MAGNESIUM INTAKE; MEAN ARTERIAL PRESSURE; MEDICAL SOCIETY; MEDICATION ERROR; META ANALYSIS (TOPIC); ORTHOSTATIC HYPOTENSION; PHYSICAL ACTIVITY; POTASSIUM INTAKE; PRACTICE GUIDELINE; PREHYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING CESSATION; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; WEIGHT CONTROL; ADULT; BLOOD PRESSURE; MALE;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; PREHYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84917690769     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2014.10.001     Document Type: Review

References (52)

1. A.V. Chobanian, G.L. Bakris, and H.R. Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report JAMA 289 2003 2560 2572
2. W.S. Aronow, J.L. Fleg, and C.J. Pepine ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension J Am Coll Cardiol 57 2011 2037 2114
3. D.A. Calhoun, D. Jones, and S. Textor Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation 117 2008 e510 e526
4. D. Lloyd-Jones, R. Adams, and M. Carnethon Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2009 e21 e181
5. W.S. Aronow, M.I. Ahmed, O.J. Ekundayo, R.M. Allman, and A. Ahmed A propensity-matched study of the association of PAD with cardiovascular outcomes in community-dwelling older adults Am J Cardiol 103 2009 130 135
6. N.R. Cook, J.A. Cutler, and E. Obarzanek Long-term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) BMJ 334 2007 885 888
7. H.Y. Chang, Y.W. Hu, and C.S. Yue Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men Am J Clin Nutr 83 2006 1289 1296
8. J.P. Midgley, A.G. Matthew, C.M. Greenwood, and A.G. Logan Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials JAMA 275 1996 1590 1597
9. US Department of Health and Human Services and US Department of Agriculture Dietary Guidelines for Americans 6th ed. 2005, January US Government Printing Office Washington, DC
10. H. Karppanen, and E. Mervaala Prog Cardiovasc Dis 49 2006 59 75
11. Q. Yang, T. Liu, and E.V. Kuklina Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey Arch Intern Med 171 2011 1183 1191
12. F.J. He, S. Pombo-Rodrigues, and G.A. Macgregor Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality BMJ Open 4 2014 e004549 10.1136/bmjopen-2013-004549
13. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 1991 3255 3264
14. H.M. Perry Jr., B.R. Davis, and T.R. Price Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke. The Systolic Hypertension in the Elderly Program (SHEP) JAMA 284 2000 465 471
15. J.B. Kostis, B.R. Davis, and J. Cutler Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension JAMA 278 1997 212 216
16. J.A. Staessen, R. Fagard, and L. Thijs Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension Lancet 350 1997 757 764
17. L. Liu, J.-G. Wang, L. Gong, G. Liu, and J.A. Staessen Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group J Hypertens 16 1998 1823 1829
18. J.A. Staessen, J. Gasowski, and J.G. Wang Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials Lancet 355 2000 865 872
19. N.S. Beckett, R. Peters, and A.E. Fletcher Treatment of hypertension in patients 80 years of age or older N Engl J Med 358 2008 1887 1898
20. C. Rosendorff, H.R. Black, and C.P. Cannon Treatment of hypertension in the prevention and management of ischemic heart disease. A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention Circulation 115 2007 2761 2788
21. W.S. Aronow Hypertension guidelines Hypertension 58 2011 347 348
22. S. Bangalore, J. Qin, S. Sloan, S.A. Murphy, C.P. Cannon PROVE-IT-TIMI 22 Trial Investigators What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 trial Circulation 122 2010 2142 2151
23. R.M. Cooper-DeHoff, Y. Gong, and E.M. Handberg Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease JAMA 304 2010 61 68
24. W.C. Cushman, G.W. Evans, R.P. Byington ACCORD Study Group Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585
25. G. Mancia, H. Schumacher, and J. Redon Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET) Circulation 124 2011 1727 1736
26. M. Banach, V. Bhatia, and M.A. Feller Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure Am J Cardiol 107 2011 1208 1214
27. A. Upadhyay, A. Earley, S.M. Haynes, and K. Uhlig Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier Ann intern Med 154 2011 541 548
28. B. Ovbiagele, H.C. Diener, and S. Yusuf Level of systolic blood pressure within the normal range and risk of recurrent stroke JAMA 306 2011 2137 2144
29. M. Banach, S. Bromfield, and G. Howard Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication Int J Cardiol 176 2014 219 226
30. M. Banach, A. Zanchetti, and S. Bromfield What is targeted diastolic blood pressure in elderly patients-the results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study (abstract) Eur Heart J 35 Suppl. 1 2014 [abstract 4799]
31. M. Banach, S. Bromfield, and A. Zanchetti Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults without antihypertensive medication (abstract) Eur Heart J 35 Suppl. 1 2014 [abstract 4765]
32. M. Ostrowski, A. Zanchetti, and S. Nikfar The effect of hypertension pharmacotherapy in older adults. The results of a meta-analysis of 11 randomized control trials with 40325 patients (abstract) Eur Heart J Suppl. 1 2014 35 [abstract 6588]
33. American Diabetes Association Position statement. Standards of Medical Care in Diabetes - 2013 Diabetes Care 36 Suppl. 1 2013 S11 S66
34. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Chapter 3. Blood pressure management in CKD ND patients without diabetes mellitus Kidney Int Suppl 2 2012 357 362
35. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Chapter 4. Blood pressure management in CKD ND patients with diabetes mellitus Kidney Int Suppl 2 2012 363 369
36. G. Mancia, R. Fagard, and K. Narkiewicz 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 34 2013 2159 2219
37. P.A. James, S. Oparil, and B.L. Carter 2014 evidence-based guideline for the management of high blood pressure in adults. Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 2014 507 520
38. J.T. Wright Jr., L.J. Fine, D.T. Lackland, G. Ogedegbe, and C. Dennison-Himmelfarb Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view Ann Intern Med 160 2014 499 503
39. A.M. Navar-Boggan, M.J. Pencina, K. Williams, A.D. Sniderman, and E.D. Peterson Proportion of US adults potentially affected by the 2014 hypertension guideline JAMA 311 2014 1424 1429
40. S. Bangalore, Y. Gong, R.M. Cooper-DeHoff, C.J. Pepine, and F.H. Messerli 2014 Eighth Joint National Committee Panel recommendation for blood pressure targets revisited: results from the INVEST study J Am Coll Cardiol 64 2014 784 793
41. M.R. Law, J.K. Morris, and N.J. Wald Use of BP lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 2009 b1665 10.1136/bmj.b1665
42. W.S. Aronow Might losartan reduce sudden cardiac death in diabetic patients with hypertension Lancet 362 2003 591 592
43. B. Carlberg, O. Samuelson, and L.H. Lindholm Atenolol in hypertension: is it a wise choice Lancet 364 2004 1684 1689
44. W.S. Aronow Current role of beta blockers in the treatment of hypertension Expert Opin Pharmacother 11 2010 2599 2607
45. C.W. Yancy, M. Jessup, and B. Bozkurt 2013 ACCF/AHA guidelines for the management of heart failure: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American College of Chest Physicians, Heart Rhythm Society, and International Society for Heart and Lung Transplantation. Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation J Am Coll Cardiol 62 2013 1495 1539
46. J.R. Chiong, W.S. Aronow, and I.A. Khan Secondary hypertension: current diagnosis and treatment Int J Cardiol 124 2008 6 21
47. K. Wheatley, N. Ives, R. Gray ASTRAL Investigators Revascularization versus medical therapy for renal-artery stenosis N Engl J Med 361 2009 1953 1962
48. C.J. Cooper, T.P. Murphy, and D.E. Cutlip Stenting and medical therapy for atherosclerotic renal-artery stenosis N Engl J Med 370 2014 13 22
49. N. Chapman, J. Dobson, and S. Wilson Effect of spironolactone on blood pressure in subjects with resistant hypertension Hypertension 49 2007 839 845
50. D.L. Bhatt, D.E. Kandzari, and W.W. O'Neill A controlled trial of renal denervation for resistant hypertension N Engl J Med 370 2014 1393 1401
51. G.L. Bakris, R.R. Townsend, and M. Liu Impact of renal denervation on 24-hour ambulatory blood pressure. Results from SYMPLICITY HTN-3 J Am Coll Cardiol 64 2014 1071 1078
52. W.S. Aronow, N.H. Lee, F.F. Sales, and F. Etienne Prevalence of postural hypotension in elderly patients in a long-term health care facility Am J Cardiol 62 1988 336